Featured Jobs
|
MAP Retirement
|
|
BPAS
|
|
July Business Services
|
|
Retirement Plan Administration Consultant Blue Ridge Associates
|
|
Regional Vice President, Sales MAP Retirement USA LLC
|
|
BPAS
|
|
Southern Pension Services
|
|
Cash Balance/ Defined Benefit Plan Administrator Steidle Pension Solutions, LLC
|
|
Managing Director - Operations, Benefits Daybright Financial
|
|
Retirement Plan Consultants
|
|
Retirement Relationship Manager MAP Retirement
|
|
ESOP Administration Consultant Blue Ridge Associates
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans Daybright Financial
|
|
BPAS
|
|
Anchor 3(16) Fiduciary Solutions
|
|
Pentegra
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Drug Pricing Issues to Watch in 2022
White & Case LLP 
Jan. 31, 2022 "Among the drug pricing developments to watch in 2022, those at the top include legislation that would allow Medicare price negotiation and alter antitrust rules for the pharmaceutical industry, Federal Trade Commission rulemaking on unfair methods of competition, and court rulings on the federal 340B drug pricing program and so-called 'patent thickets.' Continuing state legislative activity on a wide range of issues, such as price transparency and drug importation, merits a close eye as well." |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |